Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Gains from Investment Securities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Gains from Investment Securities for 10 consecutive years, with -$46000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 108.88% to -$46000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $906000.0 through Dec 2025, down 66.28% year-over-year, with the annual reading at $164013.0 for FY2025, 97.55% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$46000.0 at Harvard Bioscience, down from $660755.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.6 million in Q2 2023, with the low at -$506000.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $241923.6, with a median of $112000.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities plummeted 169.13% in 2021, then skyrocketed 35339.65% in 2025.
  • Over 5 years, Gains from Investment Securities stood at -$506000.0 in 2021, then surged by 108.1% to $41000.0 in 2022, then skyrocketed by 953.66% to $432000.0 in 2023, then grew by 19.91% to $518000.0 in 2024, then crashed by 108.88% to -$46000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$46000.0, $660755.0, and $708793.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.